globulin fraction of blood termed renin-activator by Kohlstaedt, Helmer, and Page (13, 14) . The product of this reaction was crystallized and named angiotonin (15, 16) . All the evidence accumulated points to the belief that angiotonin is the effector substance and that renin is a vaso-inactive, mother substance.
The stimulus to liberation of renin from isolated perfused kidneys is reduction of pulse pressure and possibly the same is true in intact animals (9) , for renal venous blood of hypertensive animals contains abundant renin in contrast to blood from normal kidneys which contains little or none (8) .
Renin is demonstrated by addition of renin-activator to plasma containing it. The addition of renin-activator is necessary because the supply of activator in the blood stream is limited (1) and addition of unusual amounts of renin quickly exhausts it (in part the phenomenon of renin "tachyphylaxis").
It appears that the renin which is liberated from the kidneys reacts with the renin-activator of the blood to produce angiotonin and this accounts for the fact that the amount of renin in the blood rapidly diminishes after leaving the kidneys and that there is little more of it in the peripheral blood of hypertensive animals than in that of normal ones (8) , but by the same token the amount of angiotonin should be increased. The purpose of this investigation was to ascertain whether this is true.
Since bilateral nephrectomy greatly enhances the pressor action of angiotonin both in intact animals and in isolated rabbits' ears perfused with angiotonin and plasma from nephrectomized animals, because of lack of inhibitor (1, 17) it seemed desirable to employ the latter preparation without addition of angiotonin. If angiotonin were contained in the peripheral blood of hypertensive animals and patients with essential hypertension, the addition of their plasma should cause marked vasoconstriction, whereas plasma from normal dogs or persons should not.
Methods
The method employed for demonstration of pressor substance has been described (1, 17) . It consists of perfusing an isolated rabbit's ear with blood or Ringer-Locke's solution using pulsatile pressure. Control injections into Ringer-Locke's solution perfusing the ear were always given to demonstrate that the plasma alone had little or no vasoconstrictor properties. Blood was removed from bilaterally nephrectomized dogs 2 days after the operation, 1 defibrinated, diluted 1 : 1 with Ringer's solution, and employed as circulating medium.
The number of drops flowing from the ear are recorded and serve as an index of both the length and intensity of vasoconstriction.
The blood to be tested was drawn from either the femoral or radial arteries or from the femoral, renal, or antecubital veins, heparinized, centrifuged, and the plasma drawn off for use. For the test, 0.4 cc. of plasma was injected. Patients with essential and malignant hypertension from the Lilly Clinic were donors. Pronounced, chronic hypertension was produced in dogs by the silk 2 perinephritis method (3), or by constricting the renal artery (Goldblatt, Lynch, Hanzal, and SummerviUe (2)), and their blood was employed for testing. When blood from the renal vein was desired, the kidneys were explanted by the method of Page and Corcoran (18) , and, after healing had occurred, the renal artery was constricted by a Goldblatt clamp to elicit hypertension.
RESULTS
When Ringer's solution is employed to perfuse the rabbit's ear and plasma from either normal or hypertensive subjects is added to it, usually no vasoconstriction results, or at most only an insignificant amount. Even if blood from normal dogs is employed, plasma from hypertensives causes only slight constriction; but, if instead of Ringer's solution or normal blood, blood taken 24 or more hours from a bilaterally nephrectomized dog is used for perfusion, then addition of only small amounts (0.4 cc.) of plasma from both hypertensive patients and dogs cause marked constriction and, contrariwise, plasma from normal man and dogs causes none (Table I) .
Plasma from the renal vein blood of normal animals or from the femoral vessels produces an insignificant amount of vasoconstriction (Table IV) . B u t plasma from the renal vein of hypertensive animals elicits marked vasoconstriction though usually somewhat less than that from the femoral vessels.
The opportunity was presented to examine the renal vein plasma of one patient with hypertension. Blood was collected from the renal vein while the patient was under ether anesthesia undergoing a sympathectomy. This was compared with blood drawn simultaneously from the antecubital vein. The plasma from the antecubital vein caused reduction of flow of 54 per cent in the rabbit's ear lasting 9 minutes, and the renal vein blood reduced the flow 45 per cent for 8 minutes. The arterial pressure before anesthesia was 210/120 mm. Hg, and while the blood was being drawn 128/80 mm. Hg. 27 days after operation when the arterial pressure was reduced to 170/110 mm. Hg the plasma caused reduction of flow of 48 per cent for 4 minutes.
2 Silk crepe has proved very satisfactory for the production of perinephritis. Nylon is reasonably satisfactory, but not as suitable as crepe silk. We have been unable to detect any consistent difference in vasoconstrictor properties between the femoral arterial and venous blood either of hypertensive dogs or man (Tables II and III) .
As a control one animal had one kidney removed and renal artery of the other almost closed by a Goldblatt clamp. Pronounced uremia occurred It will also be observed that the plasma from hypertensives causes greater vasoconstriction than does normal plasma when mixed with angiotonin and injected, confirming earlier work (14) . DISCUSSION Plasma from patients with essential hypertension or chronic Bright's disease with hypertension causes marked vasoconstriction when perfused in small amounts through a rabbit's ear irrigated with blood from a nephrectomized dog. The same type of vasoconstriction occurs when plasma of dogs made hypertensive either by perinephritis or constricting the renal artery is employed. The most marked vasoconstriction is produced by blood drawn from the peripheral vessels and somewhat less by that from the renal veins. It is our belief that these results are best explained on the basis of the renin-angiotonin vasopressor system. Renin is liberated from the kidneys into the renal veins as the result, for instance, of reduction of pulse pressure (9) . It reacts with the renin-activator in the blood causing it to diminish in amount steadily after leaving the kidneys (8) . On reaching the periphery, little appears to remain in the blood. The product of the reaction between renin and renin-activator, at least ~n vitro, is the water-soluble, dialyzable pressor substance called angiotonin (15, 16) . If a similar reaction occurs, in vivo, the renin should be replaced by angiotonin.
It has been shown that angiotonin requires the presence of a second substance, angiotonin-activator, to exert its full vasoconstrictor action in organs perfused with Ringer's solution (17) . This activator is supplied abundantly by normal blood. But normal blood appears to contain a substance having its origin in the kidneys which inhibits the action of angiotonin (1, 17) . Hence to elicit maximum vasoconstriction from angiotonin in a perfused organ, the perfusing fluid would best be blood from a nephrectomized animal. For these reasons the rabbit's ear perfused with blood from dogs with both kidneys removed was used as a method to demonstrate the presence of angiotonin. The marked vasoconstriction elicited by plasma from hypertensives under these circumstances suggests strongly that such blood contains angiotonin.
A means would, therefore, seem to be at hand for differentiating hypertension of renal from that of other origins. Among the patients examined, plasma from typical cases of essential hypertension, essential hypertension with the diencephalic syndrome, malignant hypertension, and Bright's disease with hypertension elicited vasoconstriction, whereas that from the group of normotensive patients did not. Similar results were obtained in comparing experimentally hypertensive and normal dogs.
The relative amounts of renin and angiotonin in the blood from the renal vein must depend on a variety of circumstances. Blood removed from the renal vein of an unanesthetized hypertensive dog appears to contain large amounts of renin (8), while blood from the renal vein of a patient under ether anesthesia contained relatively more angiotonin. More extensive investigation of this problem is required as it might furnish the clue to the problem of which kidney to remove in so called unilateral renal disease. It would seem reasonable to remove the kidney which is liberating renin and angiotonin.
These observations and those demonstrating that the renin-and angiotonin-activator content of the blood is increased or the inhibitor content decreased, or both (8, 14) , add cogent evidence, we believe, to the identity of the chemical mediator in all of these clinical types of hypertension and to the belief that the mediator is angiotonin or one of its derivatives.
It is difficult at present to know how to fit our observation with those of Houssay and his collaborators. Fasciolo, Houssay, and Taquini (21) showed that grafting a markedly ischemic kidney onto the neck vessels of a dog produced a rise of blood pressure. Others have confirmed this observa-tion. Their observation may be taken as indicating the liberation of a substance from the ischemic kidney which in the presence of blood causes a rise in arterial pressure. The observation of Houssay and Taquini (22) that plasma of citrated venous blood from an ischemic kidney produced vasoconstriction in a perfused toad, whereas normal blood did not, needs further investigation as Mason and Rozzell (23) were unable to verify it. Braun-Menendez, Fasciolo, Leloir, and Mufioz (24) noted greater than normal pressor action of extracts prepared from renal vein blood of ischemic kidneys, and Braun-Menendez and Fasciolo (25) found serum (10 to 20 cc.) prepared from blood of a perfused ischemic kidney to cause a greater rise in blood pressure of anesthetized dogs than serum of blood from normal kidneys. It is not known why such small amounts of serum cause rise in arterial pressure when large transfusions of blood from hypertensive animals appear to cause comparatively little pressor action. Whether the extracts prepared from renal vein blood contain angiotonin remains to be determined. These important observations add weight to the belief that pressor substances are in fact liberated by the kidneys. SUMMARY I. Plasma from the renal vein, femoral artery or vein of normal dogs and plasma from the femoral artery, femoral and antecubital veins of man cause little or no vasoconstriction when added in small amounts to blood from a bilaterally nephrectomized dog used as perfusing medium in an isolated rabbit's ear.
2. Plasma from the femoral vessels and antecubital vein of patients with essential hypertension, malignant hypertension, and chronic nephritic hypertension causes marked vasoconstriction under the same circumstances. The plasma of dogs made hypertensive either by constriction of the parenchyma by the scar of silk perinephritis or by constriction of the renal artery by a clamp also causes pronounced vasoconstriction.
3. Plasma from the renal vein of normal dogs produces little or no vasoconstriction, but that of hypertensive dogs elicits vasoconstriction but usually not so marked as that elicited by plasma collected from peripheral vessels. A sample of renal venous plasma from one hypertensive patient caused severe vasoconstriction, not quite so intense as that produced by the peripheral vein plasma.
4. Since renin is liberated into the renal vein in large amounts in hypertensive dogs and reacts with renin-activator to produce angiotonin and since the conditions of the experiment are such as to enhance greatly the sensitivity of the ear preparation to angiotonin, it is believed that the vaso-constriction is the result of the presence of angiotonin in the peripheral blood.
5. Since vasoconstriction occurs under the same experimental conditions with plasma from both hypertensive patients and dogs, this is considered cogent evidence in favor of the view that the chemical mediator of both is similar and is possibly angiotonin.
6. A method is presented which is believed will distinguish between plasma from patients with normal blood pressure and that from those with hypertension, and between plasma from normal dogs and that from dogs with experimental renal hypertension.
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